Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Multiple New Multi-Commodity Targets May 12, 2025 Next Post Walgreens doubles down on prescription-filling robots to cut costs, free up pharmacists amid turnaround May 13, 2025 Related Posts 400% Increase in Antimony Target Strike Length October 10, 2025 Locksley Resources Limited400% Increase in Antimony Target Strike Length October 10, 2025 RemSense Technologies October 10, 2025